Platelet-Rich Protein and the Endometrium

Hadassah Medical Center

Status: Unknown

Conditions: Infertility

Treatments: Other: PRP injection

Study type: Interventional

Funder types: Other

Identifiers

NCT02973555

PRP-HMO-CTIL

Details and patient eligibility

About

Platelet-rich plasma (PRP) may promote the endometrial growth and improve pregnancy outcome of patients with thin endometrium undergoing ART treatments.

Enrollment: 50 estimated patients

Sex: Female

Ages: 18 to 54 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women undergoing a frozen thawed embryo transfer cycle with poor endometrial response to estrogen (< 7 mm) after at least two standard preparation protocols, of which one was canceled due to thin endometrium

Exclusion criteria

• none

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

PRP injection

Experimental group

Treatment:

Other: PRP injection